低级别胶质瘤患者的疲劳:评估方法与患病率的系统评价
该系统评价检索 PubMed、Embase 和 PsychINFO,纳入 19 篇文献共 971 例低级别胶质瘤患者,识别出 7 种自评工具,疲劳患病率范围为 39% 至 77%;疲劳是治疗的常见副作用,轻度或中度副作用时患病率为 20% 至 76%,严重副作用时为 4%。
要点
- 低级别胶质瘤患者疲劳患病率范围为 39% 至 77%,共识别 7 种自评工具。
- 疲劳作为治疗副作用时,轻度或中度患病率为 20% 至 76%,严重时为 4%。
- 作者认为疲劳是低级别胶质瘤患者的常见问题,值得更多治疗和科学关注。
核心结论
- 疲劳是低级别胶质瘤患者的常见问题,值得更多治疗和科学关注。
- 深入了解疲劳的潜在机制对于个体化靶向治疗至关重要。
研究设计与样本
- 系统评价,检索 PubMed、Embase 和 PsychINFO 中报告低级别胶质瘤患者疲劳的文章。
- 纳入标准为疑似或确诊低级别胶质瘤、疲劳作为主要或次要结局、年龄≥18 岁、英文或荷兰文全文。
- 共纳入 19 篇文章,包括 971 例患者。
- 两名评价者独立提取数据。
主要发现
- 共识别 7 种自评工具。
- 疲劳患病率范围为 39% 至 77%。
- 疲劳是治疗的常见副作用。
- 疲劳报告为轻度或中度副作用时,患病率范围为 20% 至 76%;报告为严重副作用时,患病率为 4%。
关键数值与推荐
- 疲劳患病率范围为 39% 至 77%。
- 疲劳作为轻度或中度副作用时患病率范围为 20% 至 76%,作为严重副作用时患病率为 4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fatigue is the most prevalent and disabling symptom in cancer patients. Yet, scientific literature on this topic is scarce and reports disparate results. This study systematically reviews how fatigue is assessed in patients with low-grade glioma and evaluates its prevalence in LGG patients. A systematic literature search was performed in PubMed, Embase and PsychINFO for articles reporting on fatigue in patients with LGG. Two reviewers independently extracted data from selected articles. Inclusion criteria were: (1) patients with suspected or confirmed LGG; (2) fatigue was assessed as primary or secondary outcome measure; (3) age≥ 18 years; (4) full-length article written in English or Dutch. In total, 19 articles were selected, including 971 patients. Seven self-assessment instruments were identified. Prevalence rates ranged from 39 to 77%. Fatigue was found to be a common side effect of treatment. The prevalence rates ranged from 20 to 76% when fatigue was reported as a mild or moderate side effect and fatigue was prevalent in 4% when reported as a severe side effect. Fatigue is a common problem in LGG patients that warrants more therapeutic and scientific attention. Gaining deeper insight in the underlying mechanisms of fatigue is essential in targeting therapy to individual patients.
引用
- van Coevorden-van Loon EMP, Coomans MB, Heijenbrok-Kal MH, et al. Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence. J Neurooncol. 2017. PMID: 28540668. doi:10.1007/s11060-017-2454-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。